Millions of patients experience persistent fatigue, weight gain, and cognitive dysfunction despite receiving normal thyroid function test results. This diagnostic paradox points to a fundamental limitation in routine thyroid screening: standard panels measure only TSH and T4, completely overlooking the autoimmune destruction occurring in Hashimoto’s thyroiditis.
Hashimoto’s thyroiditis accounts for approximately 90 percent of hypothyroidism cases in iodine-sufficient countries, yet conventional testing fails to detect elevated thyroid antibodies that may be actively attacking thyroid tissue. According to recent clinical evidence, thyroid peroxidase (TPO) and thyroglobulin (Tg) antibodies can rise significantly while TSH remains within normal reference ranges.
Clinicians and patients alike should recognize that comprehensive thyroid assessment requires antibody testing alongside hormone measurement, particularly when symptoms persist despite normal hormone panels. Early detection of thyroid antibodies enables preventive intervention before overt thyroid failure develops.
Was this article helpful?
